HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.

AbstractBACKGROUND:
Most group A streptococcal (GAS) vaccine strategies have focused on the surface M protein, a major virulence factor of GAS. The amino-terminus of the M protein elicits antibodies, that are both opsonic and protective, but which are type specific. J14, a chimeric peptide that contains 14 amino acids from the M protein conserved C-region at the carboxy-terminus, offers the possibility of a vaccine which will elicit protective opsonic antibodies against multiple different GAS strains. In this study, we searched for J14 and J14-like sequences and the number of their repeats in the C-region of the M protein from GAS strains isolated from the Northern Thai population. Then, we examined the bactericidal activity of J14, J14.1, J14-R1 and J14-R2 antisera against multiple Thai GAS strains.
RESULTS:
The emm genes of GAS isolates were sequenced and grouped as 14 different J14-types. The most diversity of J14-types was found in the C1-repeat. The J14.1 type was the major sequence in the C2 and C3-repeats. We have shown that antisera raised against the M protein conserved C-repeat region peptides, J14, J14.1, J14-R1 and J14-R2, commonly found in GAS isolates from the Northern Thai population, are able to kill GAS of multiple different emm types derived from an endemic area. The mean percent of bactericidal activities for all J14 and J14-like peptide antisera against GAS isolates were more than 70%. The mean percent of bactericidal activity was highest for J14 antisera followed by J14-R2, J14.1 and J14-R1 antisera.
CONCLUSION:
Our study demonstrated that antisera raised against the M protein conserved C-repeat region are able to kill multiple different strains of GAS isolated from the Northern Thai population. Therefore, the four conserved "J14" peptides have the potential to be used as GAS vaccine candidates to prevent streptococcal infections in an endemic area.
AuthorsNonglak Yoonim, Colleen Olive, Chulabhorn Pruksachatkunakorn, Sumalee Pruksakorn
JournalBMC microbiology (BMC Microbiol) Vol. 6 Pg. 71 (Aug 09 2006) ISSN: 1471-2180 [Electronic] England
PMID16895610 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies
  • Antigens, Bacterial
  • Bacterial Outer Membrane Proteins
  • Carrier Proteins
  • Peptide Fragments
  • Streptococcal Vaccines
  • streptococcal M protein
Topics
  • Amino Acid Sequence
  • Antibodies (administration & dosage, blood, immunology)
  • Antigens, Bacterial (chemistry, genetics, immunology)
  • Bacterial Outer Membrane Proteins (chemistry, genetics, immunology)
  • Carrier Proteins (chemistry, genetics, immunology)
  • Conserved Sequence (genetics)
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Molecular Sequence Data
  • Peptide Fragments (chemistry, immunology)
  • Polymerase Chain Reaction
  • Streptococcal Infections (immunology, prevention & control)
  • Streptococcal Vaccines (administration & dosage, chemistry, immunology)
  • Streptococcus pyogenes (immunology, isolation & purification, metabolism)
  • Terminal Repeat Sequences (genetics)
  • Thailand

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: